ITEMGROUPDATASEQ,STUDYID,DOMAIN,ETCD,ELEMENT,TESTRL,TEENRL
1,CDISCPILOT01,TE,SCREEN,Screening,Date of informed consent,"Completion of all screening activities, no more than 2 weeks from informed consent"
2,CDISCPILOT01,TE,PLACEBO,Placebo,First dose when drug is Placebo,26 weeks after the start of the Element
3,CDISCPILOT01,TE,LOW,Zanomaline 54 mg,First dose when Dose=54 mg,26 weeks after the start of the Element
4,CDISCPILOT01,TE,TITRATE,Zanomaline 54 mg Titration,First dose of titration period,2 weeks after the start of the Element
5,CDISCPILOT01,TE,HIGH,Zanomaline 81 mg,First dose when Dose=81 mg,22 weeks after the start of the Element
